PE20081195A1 - Derivado de 2-piridincarboxamida que tiene efecto activador de gk - Google Patents

Derivado de 2-piridincarboxamida que tiene efecto activador de gk

Info

Publication number
PE20081195A1
PE20081195A1 PE2007001346A PE2007001346A PE20081195A1 PE 20081195 A1 PE20081195 A1 PE 20081195A1 PE 2007001346 A PE2007001346 A PE 2007001346A PE 2007001346 A PE2007001346 A PE 2007001346A PE 20081195 A1 PE20081195 A1 PE 20081195A1
Authority
PE
Peru
Prior art keywords
methyl
thio
triazol
carboxamide
pyridin
Prior art date
Application number
PE2007001346A
Other languages
English (en)
Inventor
Noriaki Hashimoto
Masanori Asai
Teruyuki Nishimura
Sagara Yufu
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of PE20081195A1 publication Critical patent/PE20081195A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

REFERIDA A UN DERIVADO DE PIRIDINCARBOXAMIDA DE FORMULA (I), DONDE R1 Y R2 SON ALQUILO C1-C6; X1 ES UN COMPUESTO: -O-(CH2)m-NR11R12 (II-1), DONDE R11 Y R12 SON H, ALQUILO C1-C6, ENTRE OTROS Y m ES UN ENTERO DE 1 A 3. SON COMPUESTOS PREFERIDOS: 3-({4-2-(DIMETILAMINO)ETOXI]FENIL}TIO)-N-(3-METIL-1,2,4-TIADIAZOL-5-IL)-6-(4-METIL-4H-1,2,4-TRIAZOL-3-IL)TIO]PIRIDIN-2-CARBOXAMIDA, 3-({4-[(1-METILAZETIDIN-3-IL)OXI]FENILTIO)-N-(3-METIL-1,2,4-TIADIAZOL-5-IL)-6-[(4-METIL-4H-1,2,4-TRIAZOL-3-IL)TIO]PIRIDIN-2-CARBOXAMIDA, N-(3-METIL-1,2,4-TIADIAZOL-5-IL)-6-[(4-METIL-4H-1,2,4-TRIAZOL-3-IL)TIO]-3-{[4-(2-PIRROLIDIN-1-ILETOXI)FENIL]TIO}PIRIDIN-2-CARBOXAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ACTIVADORES DE LA GLUCOQUINASA Y SON UTILES EN EL TRATAMIENTO DE LA DIABETES Y LA OBESIDAD
PE2007001346A 2006-10-06 2007-10-04 Derivado de 2-piridincarboxamida que tiene efecto activador de gk PE20081195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006275824 2006-10-06

Publications (1)

Publication Number Publication Date
PE20081195A1 true PE20081195A1 (es) 2008-09-04

Family

ID=39282963

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001346A PE20081195A1 (es) 2006-10-06 2007-10-04 Derivado de 2-piridincarboxamida que tiene efecto activador de gk

Country Status (22)

Country Link
US (1) US8338460B2 (es)
EP (1) EP2077266B1 (es)
JP (1) JP5292100B2 (es)
KR (1) KR20090060426A (es)
CN (1) CN101522673A (es)
AR (1) AR063028A1 (es)
AU (1) AU2007307560B2 (es)
BR (1) BRPI0716590A2 (es)
CA (1) CA2667068C (es)
CL (1) CL2007002890A1 (es)
CO (1) CO6180507A2 (es)
CR (1) CR10673A (es)
GT (1) GT200900065A (es)
IL (1) IL197714A0 (es)
MA (1) MA30813B1 (es)
MX (1) MX2009003073A (es)
NO (1) NO20091793L (es)
PE (1) PE20081195A1 (es)
RU (1) RU2009117209A (es)
SV (1) SV2009003196A (es)
TW (1) TW200831504A (es)
WO (1) WO2008044777A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4400563B2 (ja) * 2003-02-13 2010-01-20 萬有製薬株式会社 新規２−ピリジンカルボキサミド誘導体
AR063028A1 (es) 2006-10-06 2008-12-23 Banyu Pharma Co Ltd Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU2008321959B2 (en) 2007-11-12 2014-02-13 Msd K.K. Heteroaryloxy quinazoline derivative
US8592428B2 (en) 2008-08-15 2013-11-26 Msd K. K. Acetyl pyrrolidinyl indole derivative
JP2012501295A (ja) * 2008-08-29 2012-01-19 Ｍｓｄ株式会社 オキソテトラヒドロフラン−２−イル−ベンズイミダゾール誘導体
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9527838B2 (en) 2012-12-17 2016-12-27 Merck Sharp & Dohme Corp. 2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment
CN113045546A (zh) * 2021-03-25 2021-06-29 浙江天宇药业股份有限公司 一种吡咯替尼杂质、其制备方法及用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
GB2277930A (en) 1993-05-11 1994-11-16 Shell Int Research Herbicidal picolinamide derivatives
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
SE0102300D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE519859C2 (sv) 2001-08-17 2003-04-15 Novacast Ab Anordning för behandling av järnlegeringar i ett kärl
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
JP4419571B2 (ja) * 2002-03-26 2010-02-24 萬有製薬株式会社 新規アミノベンズアミド誘導体
JP4400563B2 (ja) 2003-02-13 2010-01-20 萬有製薬株式会社 新規２−ピリジンカルボキサミド誘導体
BRPI0407810A (pt) 2003-02-26 2006-03-01 Banyu Pharma Co Ltd composto, composição farmacêutica, ativador da glicocinase, e, medicamento
WO2005012256A1 (en) 2003-07-22 2005-02-10 Astex Therapeutics Limited 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
US20050176767A1 (en) 2003-10-30 2005-08-11 Laval Chan Chun Kong Pyridine carboxamide and methods for inhibiting HIV integrase
US7435831B2 (en) 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
GB0412468D0 (en) 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds
KR100716891B1 (ko) 2005-11-01 2007-05-09 (주)아모레퍼시픽 피리딘 티아졸 카복사마이드 유도체, 이의 제조방법 및이를 함유하는 피부 미백용 조성물
US7951824B2 (en) 2006-02-17 2011-05-31 Hoffman-La Roche Inc. 4-aryl-pyridine-2-carboxyamide derivatives
EP1849785A1 (en) 2006-04-28 2007-10-31 Neuropharma, S.A. N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
AR063028A1 (es) 2006-10-06 2008-12-23 Banyu Pharma Co Ltd Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
AU2007307560B2 (en) 2012-10-04
IL197714A0 (en) 2009-12-24
SV2009003196A (es) 2009-07-28
CL2007002890A1 (es) 2008-01-18
RU2009117209A (ru) 2010-11-20
EP2077266B1 (en) 2012-07-25
CN101522673A (zh) 2009-09-02
CA2667068A1 (en) 2008-04-17
GT200900065A (es) 2010-04-28
AR063028A1 (es) 2008-12-23
AU2007307560A1 (en) 2008-04-17
BRPI0716590A2 (pt) 2012-12-25
WO2008044777A1 (en) 2008-04-17
JPWO2008044777A1 (ja) 2010-02-18
KR20090060426A (ko) 2009-06-12
JP5292100B2 (ja) 2013-09-18
NO20091793L (no) 2009-05-05
EP2077266A4 (en) 2010-07-07
MX2009003073A (es) 2009-04-02
CA2667068C (en) 2012-03-27
CR10673A (es) 2009-09-03
EP2077266A1 (en) 2009-07-08
US8338460B2 (en) 2012-12-25
US20080090799A1 (en) 2008-04-17
TW200831504A (en) 2008-08-01
MA30813B1 (fr) 2009-10-01
CO6180507A2 (es) 2010-07-19

Similar Documents

Publication Publication Date Title
PE20081195A1 (es) Derivado de 2-piridincarboxamida que tiene efecto activador de gk
PE20110063A1 (es) DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
PE20110598A1 (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
PE20061366A1 (es) Compuestos y composiciones como inhibidores de quinasa de proteina
ATE442349T1 (de) Diacylglycerol-acyltransferase-hemmer
CR8505A (es) Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
NO20084403L (no) Cykloheksylpyrazol-lactamderivater som inhibitorer av II-beta-hydroksysteroid dehydrogenase I
PE20081471A1 (es) Derivados de heteroarilnitrilo como inhibidores de cisteina proteasa
PE20090886A1 (es) Nuevos inhibidores de quinasa
PE20090813A1 (es) Inhibidores de la 11b-hidroxiesteroide-deshidrogenasa
PE20061394A1 (es) Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas
PE20090288A1 (es) Derivados de quinoxalina como inhibidores de la pi3 quinasa
NO20084418L (no) Azolopyridin-3-on derivater som inhibitorer av endoteliallipase
NO20080391L (no) Pyrazolbaserte LXR modulatorer
PE20090641A1 (es) Amidas heterociclicas
NO20084318L (no) Inhibitorer av II-beta-hydroksystereoid dehydrogenase I
NO20083514L (no) Heterobicykliske sulfonamidderivater for behandling av diabetes
NZ590355A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
PE20080972A1 (es) Inhibidores de rho cinasa
PE20081532A1 (es) Compuestos novedosos
PE20110136A1 (es) Compuestos organicos
PE20060530A1 (es) Aril y heteroaril derivados sustituidos como moduladores del metabolismo de la glucosa
NO20074872L (no) Pyrazoler
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer

Legal Events

Date Code Title Description
FC Refusal